Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Junko Fukumura"'
Autor:
Paola Nicoletti, Hisashi Anayama, Yasunori Nio, Yui Noguchi, Paul B. Watkins, Takanori Takebe, Momoko Ohori, Eri Kawakami, Guruprasad P. Aithal, Masaru Koido, Tadahiro Shinozawa, Junko Fukumura, Ann K. Daly, Yvonne P. Dragan
Publikováno v:
Nat Med
Drug-induced liver injury (DILI) is a leading cause of termination in drug development programs and removal of drugs from the market; this is partially due to the inability to identify patients who are at risk1. In this study, we developed a polygeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e2931a5dda5b2e2f7d2b4a5e3b0f9a
https://europepmc.org/articles/PMC8482794/
https://europepmc.org/articles/PMC8482794/
Autor:
Junko Fukumura, Naoki Harada, Koh Furugaki, Kaname Yamamoto, Mitsue Kurasawa, Keigo Yorozu, Mieko Yanagisawa, Kenichi Suda, Yoichiro Moriya, Toshiki Iwai, Tetsuya Mitsudomi, Hiroshi Mizuuchi
Publikováno v:
International Journal of Cancer. 138:1024-1032
Erlotinib (ERL), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, shows notable efficacy against non-small cell lung cancer (NSCLC) harboring EGFR mutations. Bevacizumab (BEV), a humanized monoclonal antibody to vascular endothel
Publikováno v:
Biomedical Research. 36:71-80
Clinical trials involving in patients with osteoporosis have reported that activated vitamin D3 (1α,25(OH)2D3, calcitriol) can prevent falling by acting on the skeletal muscles. However, pharmacological mechanisms of 1α,25(OH)2D3 with respect to sk
Autor:
Naohiko, Hayakawa, Junko, Fukumura, Hideyuki, Yasuno, Kaori, Fujimoto-Ouchi, Hidemitsu, Kitamura
Publikováno v:
Biomedical research (Tokyo, Japan). 36(2)
Clinical trials involving in patients with osteoporosis have reported that activated vitamin D3 (1α,25(OH)2D3, calcitriol) can prevent falling by acting on the skeletal muscles. However, pharmacological mechanisms of 1α,25(OH)2D3 with respect to sk
Autor:
Koh, Furugaki, Junko, Fukumura, Toshiki, Iwai, Keigo, Yorozu, Mitsue, Kurasawa, Mieko, Yanagisawa, Yoichiro, Moriya, Kaname, Yamamoto, Kenichi, Suda, Hiroshi, Mizuuchi, Tetsuya, Mitsudomi, Naoki, Harada
Publikováno v:
International journal of cancer. 138(4)
Erlotinib (ERL), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, shows notable efficacy against non-small cell lung cancer (NSCLC) harboring EGFR mutations. Bevacizumab (BEV), a humanized monoclonal antibody to vascular endothel
Publikováno v:
Experimental Cell Research. 300:213-222
We investigated the function of DDX3Y, the Y chromosome AZFa region encoding a putative DEAD-box RNA helicase protein, the loss of which results in oligozoospermia or azoospermia in humans. The human DDX3Y amino acid sequence is similar to that of th
Publikováno v:
Journal of Biochemistry. 134:71-82
ts ET24 cells are a novel temperature-sensitive (ts) mutant for cell proliferation of hamster BHK21 cells. The human genomic DNA which rescued the temperature-sensitive lethality of ts ET24 cells was isolated and screened for an open reading frame in
Autor:
Junko Fukumura, Takeshi Sekiguchi
Publikováno v:
The Journal of biological chemistry.
Withdrawn by the Author.
Autor:
Yusuke Sasaki, Mariko Noguchi-Sasaki, Yukari Matsuo, Junko Fukumura, Fumi Sato-Inomata, Keigo Yorozu, Yasushi Shimonaka
Publikováno v:
Blood. 122:3444-3444
Introduction Erythropoiesis and iron metabolism are inextricably linked. Developing immature erythroblasts have an extremely high iron requirement, especially during hemoglobin synthesis. Hepcidin, which inhibits iron efflux by binding to iron export